Rebus Holdings, Inc. (RBSH)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Rebus Holdings Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.129M |
| September 30, 2022 | -0.131M |
| June 30, 2022 | -0.322M |
| March 31, 2022 | -0.124M |
| December 31, 2021 | -0.284M |
| September 30, 2021 | -0.135M |
| June 30, 2021 | -0.128M |
| March 31, 2021 | -0.146M |
| December 31, 2020 | -0.129M |
| September 30, 2020 | -0.083M |
| June 30, 2020 | -0.035M |
| March 31, 2020 | -0.127M |
| December 31, 2019 | -0.027M |
| September 30, 2019 | -0.179M |
| June 30, 2019 | -0.047M |
| March 31, 2019 | -0.06M |
| December 31, 2018 | -0.043M |
| September 30, 2018 | -0.155M |
| June 30, 2018 | -0.003M |
| March 31, 2018 | -0.003M |
| December 31, 2017 | -0.008M |
| September 30, 2017 | -0.261M |
| June 30, 2017 | -0.117M |
| Date | Value |
|---|---|
| March 31, 2017 | -0.706M |
| December 31, 2016 | -0.598M |
| September 30, 2016 | -0.596M |
| June 30, 2016 | -0.632M |
| March 31, 2016 | -0.907M |
| December 31, 2015 | -1.013M |
| September 30, 2015 | -1.142M |
| June 30, 2015 | -1.282M |
| March 31, 2015 | -1.196M |
| December 31, 2014 | -1.243M |
| September 30, 2014 | -1.23M |
| June 30, 2014 | -1.562M |
| March 31, 2014 | -1.009M |
| December 31, 2013 | -1.278M |
| September 30, 2013 | -1.28M |
| June 30, 2013 | -1.139M |
| March 31, 2013 | -1.01M |
| December 31, 2012 | -1.047M |
| September 30, 2012 | -1.461M |
| June 30, 2012 | -0.9687M |
| March 31, 2012 | -1.044M |
| December 31, 2011 | -1.124M |
| September 30, 2011 | -1.260M |
| June 30, 2011 | -1.027M |
| March 31, 2011 | -0.3337M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
| Anika Therapeutics, Inc. | -0.684M |
| Savara, Inc. | -29.75M |
| Vericel Corp. | 16.19M |